Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
Watchlist
Compare
18.81
-0.40 (-2.08%)
Aug 11, 2025, 2:01 PM - Market open
Overview
Financials
Forecast
Statistics
Metrics
Dividends
History
Profile
Chart
Metrics
Revenue by Type
Software Products and Services Revenue Breakdown
Drug Discovery Revenue Breakdown
Revenue by Geography
Schrödinger Revenue by Type
Quarterly
TTM
Download
Period Ending
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Software Products and Services
195.80M
180.40M
169.40M
166.42M
160.37M
159.17M
138.27M
134.03M
Upgrade
Upgrade
Software Products and Services Growth
22.09%
13.34%
22.52%
24.17%
19.07%
17.42%
-
-
Upgrade
Upgrade
Drug Discovery
34.77M
27.22M
24.02M
34.28M
28.19M
57.57M
61.07M
59.72M
Upgrade
Upgrade
Drug Discovery Growth
23.37%
-52.72%
-60.67%
-42.60%
-54.79%
26.94%
-
-
Upgrade
Upgrade
Software Products and Services Revenue Breakdown
Period Ending
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Software Products and Services
111.82M
104.02M
102.57M
104.13M
102.19M
104.51M
84.19M
82.96M
Upgrade
Upgrade
Software Products and Services
111.82M
104.02M
102.57M
104.13M
102.19M
104.51M
84.19M
82.96M
Upgrade
Upgrade
Drug Discovery
38.95M
35.25M
30.09M
26.74M
23.11M
20.38M
18.49M
16.94M
Upgrade
Upgrade
Software Products and Services Growth
9.43%
-0.47%
21.83%
25.51%
23.50%
23.70%
-
-
Upgrade
Upgrade
Drug Discovery
38.95M
35.25M
30.09M
26.74M
23.11M
20.38M
18.49M
16.94M
Upgrade
Upgrade
Drug Discovery Growth
68.57%
72.97%
62.75%
57.85%
43.64%
36.88%
-
-
Upgrade
Upgrade
Software Contribution
11.86M
8.02M
3.12M
-
-
-
1.80M
-
Upgrade
Upgrade
Software Contribution Growth
-
-
73.56%
-
-
-
-
-
Upgrade
Upgrade
Drug Discovery Revenue Breakdown
Period Ending
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Drug Discovery Services Customer Contracts
32.69M
25.14M
21.97M
31.88M
25.61M
54.72M
58.22M
57.20M
Upgrade
Upgrade
Drug Discovery Services Customer Contracts Growth
27.64%
-54.05%
-62.27%
-44.26%
-57.31%
26.00%
-
-
Upgrade
Upgrade
Drug Discovery Contribution
2.04M
2.03M
2.02M
2.37M
2.55M
2.82M
2.88M
2.54M
Upgrade
Upgrade
Drug Discovery Contribution Growth
-19.95%
-28.03%
-29.72%
-6.89%
7.24%
44.72%
-
-
Upgrade
Upgrade
Revenue by Geography
Period Ending
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
United States
121.24M
114.87M
133.14M
141.65M
134.91M
161.96M
146.14M
140.49M
Upgrade
Upgrade
United States Growth
-10.14%
-29.08%
-8.89%
0.83%
-6.07%
31.08%
-
-
Upgrade
Upgrade
EMEA
81.54M
65.65M
33.86M
32.48M
29.50M
29.14M
27.69M
28.36M
Upgrade
Upgrade
EMEA Growth
176.37%
125.33%
22.28%
14.51%
3.03%
-15.43%
-
-
Upgrade
Upgrade
APAC
26.38M
25.80M
25.18M
25.47M
23.00M
24.57M
31.14M
30.47M
Upgrade
Upgrade
APAC Growth
14.69%
5.02%
-19.14%
-16.40%
-15.44%
13.33%
-
-
Upgrade
Upgrade
Rest of World
1.35M
1.22M
1.16M
1.03M
1.07M
1.00M
-5.59M
-5.52M
Upgrade
Upgrade
Rest of World Growth
25.94%
21.68%
-
-
-
-21.06%
-
-
Upgrade
Upgrade
Source:
Business metrics provided by
Main Street Data
and sourced from official company press releases and documents.